[ Price : $8.95]
FDA cautions consumers not to consider hyperbaric oxygen therapy for unapproved indications[ Price : $8.95]
Alston & Bird attorneys say that a FDA draft guidance on medical device cybersecurity raises many questions and concerns.[ Price : $8.95]
Citing positive results from a Phase 2 study, Incyte says it is planning a Phase 3 trial involving ruxolitinib, its oral JAK1 and ...[ Price : $8.95]
FDA advises consumers not to use Ortiga, an unapproved product promoted for a variety of health conditions and sold on multiple We...[ Price : $8.95]
FDA encourages pharmacies not to use Front Range Laboratories for quality testing services.[ Price : $8.95]
Federal Register Notice: FDA establishes a docket to receive comments on an FDA report on clinical trial participation by demograp...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Compliance With Regulations Restricting the Sale and Distribution of Cigarettes ...[ Price : $8.95]
FDA approves a Transdermal Delivery Solutions IND to evaluate Testagen TDS for treating low testosterone in men.